How Rescheduling Hydrocodone Combination Products Will Reduce Abuse

Published Online: Wednesday, January 22, 2014
Follow Pharmacy_Times:
In this video, Mary Lynn McPherson, PharmD, professor and vice chair at the University of Maryland School of Pharmacy, explains how rescheduling hydrocodone combination products as Schedule II drugs will help reduce levels of abuse.
 
This is the seventh in a series of videos in which Dr. McPherson argues in favor of categorizing hydrocodone combination products as Schedule II drugs, and Jeff Fudin, PharmD, argues against doing so. (Drs. McPherson and Fudin were assigned to take these positions for a session at the American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting in Orlando, and their arguments do not necessarily reflect their personal positions on the issue.)
 
These videos were filmed at the ASHP 2013 Midyear Clinical Meeting in Orlando.

Related Articles
The Kentucky Board of Pharmacy has passed an emergency regulation permitting the state’s pharmacists to dispense the opioid overdose antidote naloxone without a prescription.
Twenty-two pharmacists and doctors were arrested in the Drug Enforcement Administration's “Operation Pilluted” aimed at curbing prescription drug abuse.
Chronic pain patients using prescription opioids in conjunction with medical marijuana are not at increased risk for substance abuse.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$